Cardiovascular outcomes following percutaneous coronary intervention with drug-eluting balloons in chronic kidney disease: a retrospective analysis
Authors:
Open Access
- 23 October 2020
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 21 (1) , 1-10
Abstract
Background: Chronic kidney disease (CKD) is associated with poorer outcomes following percutaneous coronary intervention (PCI) with drug-eluting stents. Drug-eluting balloons are used for in-stent restenosis and selected cases of de-novo coronary lesions. Little is known regarding the outcomes of individuals with CKD who undergo PCI with drug-eluting balloons. The goal of this study was to assess outcomes of PCI with drug-eluting balloons in individuals with CKD.Methods: In a retrospective analysis, outcomes of PCI with drug-eluting balloons were compared between 101 patients with CKD and 261 without CKD. CKD was defined as estimated glomerular filtration rate < 60 ml/min/1.73m2. We compared demographics, procedure data and clinical outcomes in the first and second years following the procedure.Results: Rates of major adverse cardiac events (MACE) and myocardial infarction were higher in patients with than without CKD: 23.8% vs. 13.8%,P < 0.005 and 15.9% vs. 3.8%,P < 0.001, respectively. Rates of target lesion revascularization were similar, 14.9 and 11.5%, respectively,P = 0.4. Shorter duration of dual anti-platelet therapy was observed among patients with than without CKD (10.0 + 3.4 vs. 10.9 + 3.7 months,P < 0.05). First-year hemorrhage episodes were similar in the two groups (0.08 ± 0.4 and 0.03 ± 0.2, respectively,P = 0.2). In a multivariate regression analysis, CKD was associated with increased risks of first year MACE (OR 2.1; 95% confidence interval 1.0-4.3,P < 0.001).Conclusions: PCI with drug-eluting balloons was associated with increased cardiovascular morbidity and mortality in patients with than without CKD. However, rates of target lesion revascularization were similar in the two groups. Shorter duration of dual anti-platelet therapy was observed in the CKD group.Keywords
This publication has 24 references indexed in Scilit:
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting StentsJACC, 2016
- Association of Chronic Renal Insufficiency With In‐Hospital Outcomes After Percutaneous Coronary InterventionJournal of the American Heart Association, 2015
- An Update on Coronary Artery Disease and Chronic Kidney DiseaseInternational Journal of Nephrology, 2014
- Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus groupClinical Research in Cardiology, 2013
- Drug eluting balloons for de novocoronary lesions – a systematic review and meta-analysisBMC Medicine, 2013
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisThe Lancet, 2010
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009
- Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2005
- Why is chronic kidney disease the “spoiler” for cardiovascular outcomes?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.JACC, 2003